Global Clinical Laboratory Services Market research and Analysis, 2015-2021
Market Insight:
The Global clinical laboratory services market is expected to grow at the CAGR of 6.4% during 2015-2022. The Global clinical laboratory services market is growing at a modest rate due to some pivotal factors that are driving the market. It includes the rising adoption of early disease detection services by specialized diagnostic tests, rising life style oriented diseases such as CVD, CHD, Cancer, Stroke and other fatal diseases. The other major driving forces includes technological advancement and rise in adoption of medical diagnostics and tests. Huge investments from government and private players is boosting the market. Investment in R&D by clinical laboratory companies have created huge scope in the market. Rising adoption of clinical laboratory services by hospitals, clinics, research institutes have created huge demand for clinical laboratory services across the globe.
Global adoption of Global clinical laboratory services by type such as clinical cytology, medical microbiology and chemistry enable the market to grow fast. These types of clinical laboratory services are majorly adopted in developed nations such as US, UK, Germany & Canada. Emerging economies such as India, China, Japan and Korea are expected to adopt considerably in next few years due to significant healthcare spending, infrastructural development and favorable government policies. The adoption of Global clinical laboratory services such as human & tumor and other esoteric tests are on rise and expected to grow at a modest rate in near future.
Global Clinical laboratory Services market by service provider are growing at a modest rate due to adoption of hospital services, cloud healthcare facilities, technological solutions, mobile apps, favorable healthcare policies and reimbursement policies. However, stringent FDA regulations and regional policies may affect the market growth of global clinical laboratory services market. The high cost of Clinical laboratory services are concern which are expected to overcome by the technological advancement and success of research & development programs by the key players.
Regional Insights:
Clinical laboratory services market have considerable demand from developed and developing economies such as US, UK, Spain, China, India and Korea. However, North America generates highest revenues across the globe due to prevalence of CVD, stroke, hypertension, cancer and other fatal related diseases followed by Europe. North America has the highest healthcare spending and R&D investments followed by Europe. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create huge opportunity for Clinical laboratory market. Improved healthcare spending, infrastructure and favorable government policies are the key factors which are expected to drive the APAC market. The report includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market.
The report also covers key factors that influence the market such as the government regulations, drug and device laws and regulations, regulations on clinical trials, government policies and so on are covered at length. Clinical laboratory Market is segmented on the basis of technology, type, application, service and geography.
COMPETITIVE INSIGHTS:
The key players contributing in Global Clinical Laboratory Market includes Abbott Laboratories, ACM Medical Laboratory, Adicon Clinical Laboratory, Arup Laboratories, Bio-Reference Laboratories, Bioscientia Healthcare, Charles River Laboratories, Inc., Clarient Inc., Genoptix Medical Laboratory, Genzyme Corporation, Healthscope Ltd., Intertek, Labco S.A., Labcorp, Lifelabs Medical Laboratory, Qiagen, Quest Diagnostics, Inc., Siemens Sonic Healthcare Limited, Spectra Laboratories, Unilabs Product launch, partnership and research and development are the key strategies adopted by market players.
MARKET SEGMENTATION:
Global Clinical laboratory Market is segmented on the basis of type, service provider and region. Global Clinical laboratory Market by type has significant contribution in generating huge revenues across the geographies. The Global Clinical laboratory Services Market by Service provider includes micro injection, embryonic cell injection, nuclear transferase technology which are adopted considerably across the globe. The rising CVD, Stroke, hypertension, Parkinson & Cancer patients are created huge demand for clinical laboratory services across the globe.
The Global clinical laboratory services market is expected to grow at the CAGR of 6.4% during 2015-2022. The Global clinical laboratory services market is growing at a modest rate due to some pivotal factors that are driving the market. It includes the rising adoption of early disease detection services by specialized diagnostic tests, rising life style oriented diseases such as CVD, CHD, Cancer, Stroke and other fatal diseases. The other major driving forces includes technological advancement and rise in adoption of medical diagnostics and tests. Huge investments from government and private players is boosting the market. Investment in R&D by clinical laboratory companies have created huge scope in the market. Rising adoption of clinical laboratory services by hospitals, clinics, research institutes have created huge demand for clinical laboratory services across the globe.
Global adoption of Global clinical laboratory services by type such as clinical cytology, medical microbiology and chemistry enable the market to grow fast. These types of clinical laboratory services are majorly adopted in developed nations such as US, UK, Germany & Canada. Emerging economies such as India, China, Japan and Korea are expected to adopt considerably in next few years due to significant healthcare spending, infrastructural development and favorable government policies. The adoption of Global clinical laboratory services such as human & tumor and other esoteric tests are on rise and expected to grow at a modest rate in near future.
Global Clinical laboratory Services market by service provider are growing at a modest rate due to adoption of hospital services, cloud healthcare facilities, technological solutions, mobile apps, favorable healthcare policies and reimbursement policies. However, stringent FDA regulations and regional policies may affect the market growth of global clinical laboratory services market. The high cost of Clinical laboratory services are concern which are expected to overcome by the technological advancement and success of research & development programs by the key players.
Regional Insights:
Clinical laboratory services market have considerable demand from developed and developing economies such as US, UK, Spain, China, India and Korea. However, North America generates highest revenues across the globe due to prevalence of CVD, stroke, hypertension, cancer and other fatal related diseases followed by Europe. North America has the highest healthcare spending and R&D investments followed by Europe. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create huge opportunity for Clinical laboratory market. Improved healthcare spending, infrastructure and favorable government policies are the key factors which are expected to drive the APAC market. The report includes detailed Market Overview, Market Determinants, Company Profiling, Sector Analysis, Market Segmentation, Geographical Analysis, Strategic Recommendations, Key Company Analysis, GAP Analysis, Key Findings, Market Estimations, Market Insights, Analyst Insights and predictive analysis of the market.
The report also covers key factors that influence the market such as the government regulations, drug and device laws and regulations, regulations on clinical trials, government policies and so on are covered at length. Clinical laboratory Market is segmented on the basis of technology, type, application, service and geography.
COMPETITIVE INSIGHTS:
The key players contributing in Global Clinical Laboratory Market includes Abbott Laboratories, ACM Medical Laboratory, Adicon Clinical Laboratory, Arup Laboratories, Bio-Reference Laboratories, Bioscientia Healthcare, Charles River Laboratories, Inc., Clarient Inc., Genoptix Medical Laboratory, Genzyme Corporation, Healthscope Ltd., Intertek, Labco S.A., Labcorp, Lifelabs Medical Laboratory, Qiagen, Quest Diagnostics, Inc., Siemens Sonic Healthcare Limited, Spectra Laboratories, Unilabs Product launch, partnership and research and development are the key strategies adopted by market players.
MARKET SEGMENTATION:
Global Clinical laboratory Market is segmented on the basis of type, service provider and region. Global Clinical laboratory Market by type has significant contribution in generating huge revenues across the geographies. The Global Clinical laboratory Services Market by Service provider includes micro injection, embryonic cell injection, nuclear transferase technology which are adopted considerably across the globe. The rising CVD, Stroke, hypertension, Parkinson & Cancer patients are created huge demand for clinical laboratory services across the globe.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. PESTEL ANALYSIS
2.4. PORTER’S FIVE FORCES MODEL
2.5. HISTORICAL ANALYSIS
2.6. CURRENT MARKET TRENDS
2.7. ANALYST INSIGHT
2.7.1. KEY FINDINGS
2.7.2. RECOMMENDATION
2.7.3. CONCLUSION
2.8. REGULATION
2.8.1. REGULATIONS ON CLINICAL TRIALS
2.8.1.1. FDA REGULATIONS
2.8.1.1.1. UNITED STATES
2.8.1.1.2. EUROPEAN UNION
2.8.1.1.3. CHINA
2.8.1.1.4. INDIA
2.8.1.1.5. REST OF THE WORLD
2.8.1.2. GOVERNMENT REGULATIONS
2.8.1.2.1. UNITED STATES
2.8.1.2.2. EUROPEAN UNION
2.8.1.2.3. CHINA
2.8.1.2.4. INDIA
2.8.1.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISE IN ADOPTION OF EARLY DISEASE DETECTION SERVICES BY SPECIALIZED DIAGNOSTIC TESTS
3.1.2. RISE IN CVD, CHD, STROKE, CANCER & OTHER LIFE STYLE ORIENTED DISEASES ACROSS THE GLOBE
3.1.3. GROWTH & ADVANCEMENT IN CLINICAL LABORATORIES MARKET
3.1.4. RISE IN ELDERLY POPULATION ACROSS THE GLOBE
3.1.5. TECHNOLOGICAL ADVANCEMENT & INNOVATION IN CLINICAL LABORATORY SERVICES MARKET
3.1.6. RESEARCH & DEVELOPMENT TO DRIVE THE CLINICAL LABORATORY MARKET
3.2. RESTRAINT
3.2.1. HIGH COST OF CLINICAL LABORATORY SERVICES, TREATMENT AND DIAGNOSIS
3.2.2. STRINGENT GOVERNMENT REGULATIONS
3.3. OPPORTUNITY
3.3.1. UNTAPPED APAC REGION IS FULL OF OPPORTUNITY FOR GLOBAL CLINICAL LABORATORY MARKET
3.3.2. CLINICAL TRIALS ARE PREDICTED TO INCREASE IN NEXT FEW YEARS
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
5.1.1. GLOBAL CLINICAL CHEMISTRY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.2. GLOBAL MEDICAL MICROBIOLOGY & CYTOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.3. GLOBAL HUMAN & TUMOUR GENETICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.4. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2. GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS, BY SERVICE PROVIDER, 2015-2021, ($ MILLIONS)
5.2.1. GLOBAL HOSPITAL BASED LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2.2. GLOBAL STAND-ALONE LABORATORIES MARKET, 2015-2021, ($ MILLIONS)
5.2.3. GLOBAL CLINIC BASED LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. INTRODUCTION
8.1.2. ABBOTT LABORATORIES PRODUCT PORTFOLIO
8.1.3. ABBOTT LABORATORIES RECENT ACTIVITIES
8.1.4. ABBOTT LABORATORIES SWOT
8.2. ACM MEDICAL LABORATORY
8.2.1. INTRODUCTION
8.2.2. ACM MEDICAL LABORATORY PRODUCT PORTFOLIO
8.2.3. ACM MEDICAL LABORATORY RECENT ACTIVITIES
8.2.4. ACM MEDICAL LABORATORY SWOT
8.3. ADICON CLINICAL LABORATORY
8.3.1. INTRODUCTION
8.3.2. ADICON CLINICAL LABORATORY PRODUCT PORTFOLIO
8.3.3. ADICON CLINICAL LABORATORY RECENT ACTIVITIES
8.3.4. ADICON CLINICAL LABORATORY SWOT
8.4. ARUP LABORATORIES
8.4.1. INTRODUCTION
8.4.2. ARUP LABORATORIES PRODUCT PORTFOLIO
8.4.3. ARUP LABORATORIES RECENT ACTIVITIES
8.4.4. ARUP LABORATORIES SWOT
8.5. BIO-REFERENCE LABORATORIES
8.5.1. INTRODUCTION
8.5.2. BIO-REFERENCE LABORATORIES PRODUCT PORTFOLIO
8.5.3. BIO-REFERENCE LABORATORIES RECENT ACTIVITIES
8.5.4. BIO-REFERENCE LABORATORIES SWOT
8.6. BIOSCIENTIA HEALTHCARE
8.6.1. INTRODUCTION
8.6.2. BIOSCIENTIA HEALTHCARE PRODUCT PORTFOLIO
8.6.3. BIOSCIENTIA HEALTHCARE RECENT ACTIVITIES
8.6.4. BIOSCIENTIA HEALTHCARE SWOT
8.7. CHARLES RIVER LABORATORIES, INC.
8.7.1. INTRODUCTION
8.7.2. CHARLES RIVER LABORATORIES, INC. PRODUCT PORTFOLIO
8.7.3. CHARLES RIVER LABORATORIES, INC. RECENT ACTIVITIES
8.7.4. CHARLES RIVER LABORATORIES, INC. SWOT
8.8. CLARIENT INC.
8.8.1. INTRODUCTION
8.8.2. CLARIENT INC. PRODUCT PORTFOLIO
8.8.3. CLARIENT INC. RECENT ACTIVITIES
8.8.4. CLARIENT INC. SWOT
8.9. GENOPTIX MEDICAL LABORATORY
8.9.1. INTRODUCTION
8.9.2. GENOPTIX MEDICAL LABORATORY PRODUCT PORTFOLIO
8.9.3. GENOPTIX MEDICAL LABORATORY RECENT ACTIVITIES
8.9.4. GENOPTIX MEDICAL LABORATORY SWOT
8.10. GENZYME CORPORATION
8.10.1. INTRODUCTION
8.10.2. GENZYME CORPORATION PRODUCT PORTFOLIO
8.10.3. GENZYME CORPORATION RECENT ACTIVITIES
8.10.4. GENZYME CORPORATION SWOT
8.11. HEALTHSCOPE LTD.
8.11.1. INTRODUCTION
8.11.2. HEALTHSCOPE LTD. PRODUCT PORTFOLIO
8.11.3. HEALTHSCOPE LTD. RECENT ACTIVITIES
8.11.4. HEALTHSCOPE LTD. SWOT
8.12. INTERTEK
8.12.1. INTRODUCTION
8.12.2. INTERTEK PRODUCT PORTFOLIO
8.12.3. INTERTEK RECENT ACTIVITIES
8.12.4. INTERTEK SWOT
8.13. LABCO S.A.
8.13.1. INTRODUCTION
8.13.2. LABCO S.A. PRODUCT PORTFOLIO
8.13.3. LABCO S.A. RECENT ACTIVITIES
8.13.4. LABCO S.A. SWOT
8.14. LABCORP
8.14.1. INTRODUCTION
8.14.2. LABCORP PRODUCT PORTFOLIO
8.14.3. LABCORP RECENT ACTIVITIES
8.14.4. LABCORP SWOT
8.15. LIFELABS MEDICAL LABORATORY
8.15.1. INTRODUCTION
8.15.2. LIFELABS MEDICAL LABORATORY PRODUCT PORTFOLIO
8.15.3. LIFELABS MEDICAL LABORATORY RECENT ACTIVITIES
8.15.4. LIFELABS MEDICAL LABORATORY SWOT
8.16. QIAGEN
8.16.1. INTRODUCTION
8.16.2. QIAGEN PRODUCT PORTFOLIO
8.16.3. QIAGEN RECENT ACTIVITIES
8.16.4. QIAGEN SWOT
8.17. QUEST DIAGNOSTICS, INC.
8.17.1. INTRODUCTION
8.17.2. QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
8.17.3. QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
8.17.4. QUEST DIAGNOSTICS, INC. SWOT
8.18. SIEMENS
8.18.1. INTRODUCTION
8.18.2. SIEMENS PRODUCT PORTFOLIO
8.18.3. SIEMENS RECENT ACTIVITIES
8.18.4. SIEMENS SWOT
8.19. SONIC HEALTHCARE LIMITED
8.19.1. INTRODUCTION
8.19.2. SONIC HEALTHCARE LIMITED PRODUCT PORTFOLIO
8.19.3. SONIC HEALTHCARE LIMITED RECENT ACTIVITIES
8.19.4. SONIC HEALTHCARE LIMITED SWOT
8.20. SPECTRA LABORATORIES
8.20.1. INTRODUCTION
8.20.2. SPECTRA LABORATORIES PRODUCT PORTFOLIO
8.20.3. SPECTRA LABORATORIES RECENT ACTIVITIES
8.20.4. SPECTRA LABORATORIES SWOT
8.21. UNILABS
8.21.1. INTRODUCTION
8.21.2. UNILABS PRODUCT PORTFOLIO
8.21.3. UNILABS RECENT ACTIVITIES
8.21.4. UNILABS SWOT
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
1.2.4. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. PESTEL ANALYSIS
2.4. PORTER’S FIVE FORCES MODEL
2.5. HISTORICAL ANALYSIS
2.6. CURRENT MARKET TRENDS
2.7. ANALYST INSIGHT
2.7.1. KEY FINDINGS
2.7.2. RECOMMENDATION
2.7.3. CONCLUSION
2.8. REGULATION
2.8.1. REGULATIONS ON CLINICAL TRIALS
2.8.1.1. FDA REGULATIONS
2.8.1.1.1. UNITED STATES
2.8.1.1.2. EUROPEAN UNION
2.8.1.1.3. CHINA
2.8.1.1.4. INDIA
2.8.1.1.5. REST OF THE WORLD
2.8.1.2. GOVERNMENT REGULATIONS
2.8.1.2.1. UNITED STATES
2.8.1.2.2. EUROPEAN UNION
2.8.1.2.3. CHINA
2.8.1.2.4. INDIA
2.8.1.2.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. RISE IN ADOPTION OF EARLY DISEASE DETECTION SERVICES BY SPECIALIZED DIAGNOSTIC TESTS
3.1.2. RISE IN CVD, CHD, STROKE, CANCER & OTHER LIFE STYLE ORIENTED DISEASES ACROSS THE GLOBE
3.1.3. GROWTH & ADVANCEMENT IN CLINICAL LABORATORIES MARKET
3.1.4. RISE IN ELDERLY POPULATION ACROSS THE GLOBE
3.1.5. TECHNOLOGICAL ADVANCEMENT & INNOVATION IN CLINICAL LABORATORY SERVICES MARKET
3.1.6. RESEARCH & DEVELOPMENT TO DRIVE THE CLINICAL LABORATORY MARKET
3.2. RESTRAINT
3.2.1. HIGH COST OF CLINICAL LABORATORY SERVICES, TREATMENT AND DIAGNOSIS
3.2.2. STRINGENT GOVERNMENT REGULATIONS
3.3. OPPORTUNITY
3.3.1. UNTAPPED APAC REGION IS FULL OF OPPORTUNITY FOR GLOBAL CLINICAL LABORATORY MARKET
3.3.2. CLINICAL TRIALS ARE PREDICTED TO INCREASE IN NEXT FEW YEARS
PARENT MARKET ANALYSIS
MARKET SEGMENTATION
5.1. GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
5.1.1. GLOBAL CLINICAL CHEMISTRY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.2. GLOBAL MEDICAL MICROBIOLOGY & CYTOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.3. GLOBAL HUMAN & TUMOUR GENETICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.1.4. GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2. GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS, BY SERVICE PROVIDER, 2015-2021, ($ MILLIONS)
5.2.1. GLOBAL HOSPITAL BASED LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
5.2.2. GLOBAL STAND-ALONE LABORATORIES MARKET, 2015-2021, ($ MILLIONS)
5.2.3. GLOBAL CLINIC BASED LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
COMPETITIVE LANDSCAPE
6.1. MARKET SHARE ANALYSIS
6.2. KEY COMPANY ANALYSIS
REGIONAL ANALYSIS
7.1. NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
7.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2. EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3. ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
7.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
7.4. REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. INTRODUCTION
8.1.2. ABBOTT LABORATORIES PRODUCT PORTFOLIO
8.1.3. ABBOTT LABORATORIES RECENT ACTIVITIES
8.1.4. ABBOTT LABORATORIES SWOT
8.2. ACM MEDICAL LABORATORY
8.2.1. INTRODUCTION
8.2.2. ACM MEDICAL LABORATORY PRODUCT PORTFOLIO
8.2.3. ACM MEDICAL LABORATORY RECENT ACTIVITIES
8.2.4. ACM MEDICAL LABORATORY SWOT
8.3. ADICON CLINICAL LABORATORY
8.3.1. INTRODUCTION
8.3.2. ADICON CLINICAL LABORATORY PRODUCT PORTFOLIO
8.3.3. ADICON CLINICAL LABORATORY RECENT ACTIVITIES
8.3.4. ADICON CLINICAL LABORATORY SWOT
8.4. ARUP LABORATORIES
8.4.1. INTRODUCTION
8.4.2. ARUP LABORATORIES PRODUCT PORTFOLIO
8.4.3. ARUP LABORATORIES RECENT ACTIVITIES
8.4.4. ARUP LABORATORIES SWOT
8.5. BIO-REFERENCE LABORATORIES
8.5.1. INTRODUCTION
8.5.2. BIO-REFERENCE LABORATORIES PRODUCT PORTFOLIO
8.5.3. BIO-REFERENCE LABORATORIES RECENT ACTIVITIES
8.5.4. BIO-REFERENCE LABORATORIES SWOT
8.6. BIOSCIENTIA HEALTHCARE
8.6.1. INTRODUCTION
8.6.2. BIOSCIENTIA HEALTHCARE PRODUCT PORTFOLIO
8.6.3. BIOSCIENTIA HEALTHCARE RECENT ACTIVITIES
8.6.4. BIOSCIENTIA HEALTHCARE SWOT
8.7. CHARLES RIVER LABORATORIES, INC.
8.7.1. INTRODUCTION
8.7.2. CHARLES RIVER LABORATORIES, INC. PRODUCT PORTFOLIO
8.7.3. CHARLES RIVER LABORATORIES, INC. RECENT ACTIVITIES
8.7.4. CHARLES RIVER LABORATORIES, INC. SWOT
8.8. CLARIENT INC.
8.8.1. INTRODUCTION
8.8.2. CLARIENT INC. PRODUCT PORTFOLIO
8.8.3. CLARIENT INC. RECENT ACTIVITIES
8.8.4. CLARIENT INC. SWOT
8.9. GENOPTIX MEDICAL LABORATORY
8.9.1. INTRODUCTION
8.9.2. GENOPTIX MEDICAL LABORATORY PRODUCT PORTFOLIO
8.9.3. GENOPTIX MEDICAL LABORATORY RECENT ACTIVITIES
8.9.4. GENOPTIX MEDICAL LABORATORY SWOT
8.10. GENZYME CORPORATION
8.10.1. INTRODUCTION
8.10.2. GENZYME CORPORATION PRODUCT PORTFOLIO
8.10.3. GENZYME CORPORATION RECENT ACTIVITIES
8.10.4. GENZYME CORPORATION SWOT
8.11. HEALTHSCOPE LTD.
8.11.1. INTRODUCTION
8.11.2. HEALTHSCOPE LTD. PRODUCT PORTFOLIO
8.11.3. HEALTHSCOPE LTD. RECENT ACTIVITIES
8.11.4. HEALTHSCOPE LTD. SWOT
8.12. INTERTEK
8.12.1. INTRODUCTION
8.12.2. INTERTEK PRODUCT PORTFOLIO
8.12.3. INTERTEK RECENT ACTIVITIES
8.12.4. INTERTEK SWOT
8.13. LABCO S.A.
8.13.1. INTRODUCTION
8.13.2. LABCO S.A. PRODUCT PORTFOLIO
8.13.3. LABCO S.A. RECENT ACTIVITIES
8.13.4. LABCO S.A. SWOT
8.14. LABCORP
8.14.1. INTRODUCTION
8.14.2. LABCORP PRODUCT PORTFOLIO
8.14.3. LABCORP RECENT ACTIVITIES
8.14.4. LABCORP SWOT
8.15. LIFELABS MEDICAL LABORATORY
8.15.1. INTRODUCTION
8.15.2. LIFELABS MEDICAL LABORATORY PRODUCT PORTFOLIO
8.15.3. LIFELABS MEDICAL LABORATORY RECENT ACTIVITIES
8.15.4. LIFELABS MEDICAL LABORATORY SWOT
8.16. QIAGEN
8.16.1. INTRODUCTION
8.16.2. QIAGEN PRODUCT PORTFOLIO
8.16.3. QIAGEN RECENT ACTIVITIES
8.16.4. QIAGEN SWOT
8.17. QUEST DIAGNOSTICS, INC.
8.17.1. INTRODUCTION
8.17.2. QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
8.17.3. QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
8.17.4. QUEST DIAGNOSTICS, INC. SWOT
8.18. SIEMENS
8.18.1. INTRODUCTION
8.18.2. SIEMENS PRODUCT PORTFOLIO
8.18.3. SIEMENS RECENT ACTIVITIES
8.18.4. SIEMENS SWOT
8.19. SONIC HEALTHCARE LIMITED
8.19.1. INTRODUCTION
8.19.2. SONIC HEALTHCARE LIMITED PRODUCT PORTFOLIO
8.19.3. SONIC HEALTHCARE LIMITED RECENT ACTIVITIES
8.19.4. SONIC HEALTHCARE LIMITED SWOT
8.20. SPECTRA LABORATORIES
8.20.1. INTRODUCTION
8.20.2. SPECTRA LABORATORIES PRODUCT PORTFOLIO
8.20.3. SPECTRA LABORATORIES RECENT ACTIVITIES
8.20.4. SPECTRA LABORATORIES SWOT
8.21. UNILABS
8.21.1. INTRODUCTION
8.21.2. UNILABS PRODUCT PORTFOLIO
8.21.3. UNILABS RECENT ACTIVITIES
8.21.4. UNILABS SWOT
LIST OF TABLES
TABLE # 1 GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
TABLE # 2 GLOBAL CLINICAL CHEMISTRY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 3 GLOBAL MEDICAL MICROBIOLOGY & CYTOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 4 GLOBAL HUMAN & TUMOR GENETICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 5 GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 6 GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS, BY SERVICE PROVIDER, 2015-2021, ($ MILLIONS)
TABLE # 7 GLOBAL HOSPITAL BASED LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 8 GLOBAL STAND-ALONE LABORATORIES MARKET, 2015-2021, ($ MILLIONS)
TABLE # 9 GLOBAL CLINIC BASED LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 10 ABBOTT LABORATORIES PRODUCT PORTFOLIO
TABLE # 11 ABBOTT LABORATORIES RECENT ACTIVITIES
TABLE # 12 ABBOTT LABORATORIES SWOT
TABLE # 13 ACM MEDICAL LABORATORY PRODUCT PORTFOLIO
TABLE # 14 ACM MEDICAL LABORATORY RECENT ACTIVITIES
TABLE # 15 ACM MEDICAL LABORATORY SWOT
TABLE # 16 ADICON CLINICAL LABORATORY PRODUCT PORTFOLIO
TABLE # 17 ADICON CLINICAL LABORATORY RECENT ACTIVITIES
TABLE # 18 ADICON CLINICAL LABORATORY SWOT
TABLE # 19 ARUP LABORATORIES PRODUCT PORTFOLIO
TABLE # 20 ARUP LABORATORIES RECENT ACTIVITIES
TABLE # 21 ARUP LABORATORIES SWOT
TABLE # 22 BIO-REFERENCE LABORATORIES PRODUCT PORTFOLIO
TABLE # 23 BIO-REFERENCE LABORATORIES RECENT ACTIVITIES
TABLE # 24 BIO-REFERENCE LABORATORIES SWOT
TABLE # 25 BIOSCIENTIA HEALTHCARE PRODUCT PORTFOLIO
TABLE # 26 BIOSCIENTIA HEALTHCARE RECENT ACTIVITIES
TABLE # 27 BIOSCIENTIA HEALTHCARE SWOT
TABLE # 28 CHARLES RIVER LABORATORIES, INC. PRODUCT PORTFOLIO
TABLE # 29 CHARLES RIVER LABORATORIES, INC. RECENT ACTIVITIES
TABLE # 30 CHARLES RIVER LABORATORIES, INC. SWOT
TABLE # 31 CLARIENT INC. PRODUCT PORTFOLIO
TABLE # 32 CLARIENT INC. RECENT ACTIVITIES
TABLE # 33 CLARIENT INC. SWOT
TABLE # 34 GENOPTIX MEDICAL LABORATORY PRODUCT PORTFOLIO
TABLE # 35 GENOPTIX MEDICAL LABORATORY RECENT ACTIVITIES
TABLE # 36 GENOPTIX MEDICAL LABORATORY SWOT
TABLE # 37 GENZYME CORPORATION PRODUCT PORTFOLIO
TABLE # 38 GENZYME CORPORATION RECENT ACTIVITIES
TABLE # 39 GENZYME CORPORATION SWOT
TABLE # 40 HEALTHSCOPE LTD. PRODUCT PORTFOLIO
TABLE # 41 HEALTHSCOPE LTD. RECENT ACTIVITIES
TABLE # 42 HEALTHSCOPE LTD. SWOT
TABLE # 43 INTERTEK PRODUCT PORTFOLIO
TABLE # 44 INTERTEK RECENT ACTIVITIES
TABLE # 45 INTERTEK SWOT
TABLE # 46 LABCO S.A. PRODUCT PORTFOLIO
TABLE # 47 LABCO S.A. RECENT ACTIVITIES
TABLE # 48 LABCO S.A. SWOT
TABLE # 49 LABCORP PRODUCT PORTFOLIO
TABLE # 50 LABCORP RECENT ACTIVITIES
TABLE # 51 LABCORP SWOT
TABLE # 52 LIFELABS MEDICAL LABORATORY PRODUCT PORTFOLIO
TABLE # 53 LIFELABS MEDICAL LABORATORY RECENT ACTIVITIES
TABLE # 54 LIFELABS MEDICAL LABORATORY SWOT
TABLE # 55 QIAGEN PRODUCT PORTFOLIO
TABLE # 56 QIAGEN RECENT ACTIVITIES
TABLE # 57 QIAGEN SWOT
TABLE # 58 QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE # 59 QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE # 60 QUEST DIAGNOSTICS, INC. SWOT
TABLE # 61 SIEMENS PRODUCT PORTFOLIO
TABLE # 62 SIEMENS RECENT ACTIVITIES
TABLE # 63 SIEMENS SWOT
TABLE # 64 SONIC HEALTHCARE LIMITED PRODUCT PORTFOLIO
TABLE # 65 SONIC HEALTHCARE LIMITED RECENT ACTIVITIES
TABLE # 66 SONIC HEALTHCARE LIMITED SWOT
TABLE # 67 SPECTRA LABORATORIES PRODUCT PORTFOLIO
TABLE # 68 SPECTRA LABORATORIES RECENT ACTIVITIES
TABLE # 69 SPECTRA LABORATORIES SWOT
TABLE # 70 UNILABS PRODUCT PORTFOLIO
TABLE # 71 UNILABS RECENT ACTIVITIES
TABLE # 72 UNILABS SWOT
TABLE # 1 GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS, BY TYPE, 2015-2021, ($ MILLIONS)
TABLE # 2 GLOBAL CLINICAL CHEMISTRY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 3 GLOBAL MEDICAL MICROBIOLOGY & CYTOLOGY MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 4 GLOBAL HUMAN & TUMOR GENETICS MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 5 GLOBAL OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 6 GLOBAL CLINICAL LABORATORY MARKET RESEARCH AND ANALYSIS, BY SERVICE PROVIDER, 2015-2021, ($ MILLIONS)
TABLE # 7 GLOBAL HOSPITAL BASED LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 8 GLOBAL STAND-ALONE LABORATORIES MARKET, 2015-2021, ($ MILLIONS)
TABLE # 9 GLOBAL CLINIC BASED LABORATORIES MARKET RESEARCH AND ANALYSIS, 2015-2021, ($ MILLIONS)
TABLE # 10 ABBOTT LABORATORIES PRODUCT PORTFOLIO
TABLE # 11 ABBOTT LABORATORIES RECENT ACTIVITIES
TABLE # 12 ABBOTT LABORATORIES SWOT
TABLE # 13 ACM MEDICAL LABORATORY PRODUCT PORTFOLIO
TABLE # 14 ACM MEDICAL LABORATORY RECENT ACTIVITIES
TABLE # 15 ACM MEDICAL LABORATORY SWOT
TABLE # 16 ADICON CLINICAL LABORATORY PRODUCT PORTFOLIO
TABLE # 17 ADICON CLINICAL LABORATORY RECENT ACTIVITIES
TABLE # 18 ADICON CLINICAL LABORATORY SWOT
TABLE # 19 ARUP LABORATORIES PRODUCT PORTFOLIO
TABLE # 20 ARUP LABORATORIES RECENT ACTIVITIES
TABLE # 21 ARUP LABORATORIES SWOT
TABLE # 22 BIO-REFERENCE LABORATORIES PRODUCT PORTFOLIO
TABLE # 23 BIO-REFERENCE LABORATORIES RECENT ACTIVITIES
TABLE # 24 BIO-REFERENCE LABORATORIES SWOT
TABLE # 25 BIOSCIENTIA HEALTHCARE PRODUCT PORTFOLIO
TABLE # 26 BIOSCIENTIA HEALTHCARE RECENT ACTIVITIES
TABLE # 27 BIOSCIENTIA HEALTHCARE SWOT
TABLE # 28 CHARLES RIVER LABORATORIES, INC. PRODUCT PORTFOLIO
TABLE # 29 CHARLES RIVER LABORATORIES, INC. RECENT ACTIVITIES
TABLE # 30 CHARLES RIVER LABORATORIES, INC. SWOT
TABLE # 31 CLARIENT INC. PRODUCT PORTFOLIO
TABLE # 32 CLARIENT INC. RECENT ACTIVITIES
TABLE # 33 CLARIENT INC. SWOT
TABLE # 34 GENOPTIX MEDICAL LABORATORY PRODUCT PORTFOLIO
TABLE # 35 GENOPTIX MEDICAL LABORATORY RECENT ACTIVITIES
TABLE # 36 GENOPTIX MEDICAL LABORATORY SWOT
TABLE # 37 GENZYME CORPORATION PRODUCT PORTFOLIO
TABLE # 38 GENZYME CORPORATION RECENT ACTIVITIES
TABLE # 39 GENZYME CORPORATION SWOT
TABLE # 40 HEALTHSCOPE LTD. PRODUCT PORTFOLIO
TABLE # 41 HEALTHSCOPE LTD. RECENT ACTIVITIES
TABLE # 42 HEALTHSCOPE LTD. SWOT
TABLE # 43 INTERTEK PRODUCT PORTFOLIO
TABLE # 44 INTERTEK RECENT ACTIVITIES
TABLE # 45 INTERTEK SWOT
TABLE # 46 LABCO S.A. PRODUCT PORTFOLIO
TABLE # 47 LABCO S.A. RECENT ACTIVITIES
TABLE # 48 LABCO S.A. SWOT
TABLE # 49 LABCORP PRODUCT PORTFOLIO
TABLE # 50 LABCORP RECENT ACTIVITIES
TABLE # 51 LABCORP SWOT
TABLE # 52 LIFELABS MEDICAL LABORATORY PRODUCT PORTFOLIO
TABLE # 53 LIFELABS MEDICAL LABORATORY RECENT ACTIVITIES
TABLE # 54 LIFELABS MEDICAL LABORATORY SWOT
TABLE # 55 QIAGEN PRODUCT PORTFOLIO
TABLE # 56 QIAGEN RECENT ACTIVITIES
TABLE # 57 QIAGEN SWOT
TABLE # 58 QUEST DIAGNOSTICS, INC. PRODUCT PORTFOLIO
TABLE # 59 QUEST DIAGNOSTICS, INC. RECENT ACTIVITIES
TABLE # 60 QUEST DIAGNOSTICS, INC. SWOT
TABLE # 61 SIEMENS PRODUCT PORTFOLIO
TABLE # 62 SIEMENS RECENT ACTIVITIES
TABLE # 63 SIEMENS SWOT
TABLE # 64 SONIC HEALTHCARE LIMITED PRODUCT PORTFOLIO
TABLE # 65 SONIC HEALTHCARE LIMITED RECENT ACTIVITIES
TABLE # 66 SONIC HEALTHCARE LIMITED SWOT
TABLE # 67 SPECTRA LABORATORIES PRODUCT PORTFOLIO
TABLE # 68 SPECTRA LABORATORIES RECENT ACTIVITIES
TABLE # 69 SPECTRA LABORATORIES SWOT
TABLE # 70 UNILABS PRODUCT PORTFOLIO
TABLE # 71 UNILABS RECENT ACTIVITIES
TABLE # 72 UNILABS SWOT
LIST OF FIGURES
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
1. ABBOTT LABORATORIES
2. ACM MEDICAL LABORATORY
3. ADICON CLINICAL LABORATORY
4. ARUP LABORATORIES
5. BIO-REFERENCE LABORATORIES
6. BIOSCIENTIA HEALTHCARE
7. CHARLES RIVER LABORATORIES, INC.
8. CLARIENT INC.
9. GENOPTIX MEDICAL LABORATORY
10. GENZYME CORPORATION
11. HEALTHSCOPE LTD.
12. INTERTEK
13. LABCO S.A.
14. LABCORP
15. LIFELABS MEDICAL LABORATORY
16. QIAGEN
17. QUEST DIAGNOSTICS, INC.
18. SIEMENS
19. SONIC HEALTHCARE LIMITED
20. SPECTRA LABORATORIES
21. UNILABS
FIGURE # 1 NORTH AMERICAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 2 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 3 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 4 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 5 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 6 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 7 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 8 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 9 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 10 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 11 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
FIGURE # 12 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANIES MENTIONED
1. ABBOTT LABORATORIES
2. ACM MEDICAL LABORATORY
3. ADICON CLINICAL LABORATORY
4. ARUP LABORATORIES
5. BIO-REFERENCE LABORATORIES
6. BIOSCIENTIA HEALTHCARE
7. CHARLES RIVER LABORATORIES, INC.
8. CLARIENT INC.
9. GENOPTIX MEDICAL LABORATORY
10. GENZYME CORPORATION
11. HEALTHSCOPE LTD.
12. INTERTEK
13. LABCO S.A.
14. LABCORP
15. LIFELABS MEDICAL LABORATORY
16. QIAGEN
17. QUEST DIAGNOSTICS, INC.
18. SIEMENS
19. SONIC HEALTHCARE LIMITED
20. SPECTRA LABORATORIES
21. UNILABS
